WorldPing
WorldPingSTAT
STAT+: FDA approves Protagonist and Takeda’s drug for rare blood cancer
Mimrylo, from Takeda and Protagonist, is a new kind of treatment for the blood cancer polycythemia vera.
Brief by WorldPing · Original reporting by STAT
STAT
STAT+: Cadre of radiopharmaceuticals experts pushes the bounds in cancer therapy
WorldPingResearchers believe radiopharmaceuticals have great promise as cancer treatments. But are they using them too timidly?
This is a short WorldPing brief. The full report was published by STAT.
Read the full report at STATRelated news
WorldPing
WorldPingFrance 24
Xi arrives for SCO summit, Putin meeting as regional bloc pushes back on US dominance
The Shanghai Cooperation Organisation summit gets underway in Kyrgyzstan, with the leaders of China and Russia attending. But first: the US hosts G20 finance ministers, while America's massive debt may be painting its new central banker into a corner.
Brief by WorldPing · Original reporting by France 24
WorldPingNPR Top
Singapore is scrambling to stabilize birthrates. Experts say there are lessons for the U.S.
Singapore has unveiled a national initiative built entirely around its collapsing birthrate. Some demographers say the plan includes policy ideas that could help American parents.
Brief by WorldPing · Original reporting by NPR Top
ESPN
US Open experts' picks: Who will win?
Americans are hoping to seize the opportunity at the US Open, with Coco Gauff, Jessica Pegula, Ben Shelton and others all in title contention.
Brief by WorldPing · Original reporting by ESPN